Invivyd (IVVD) Change in Account Payables (2021 - 2025)
Invivyd (IVVD) posted Change in Account Payables of -$4.2 million for Q4 2025, down 1847.71% on a QoQ basis from -$218000.0 in Q3 2025, and up 41.76% year-over-year from -$3.0 million in Q4 2024.
Invivyd (IVVD) Change in Account Payables (2021 - 2025) Analysis & Trends
Invivyd's Change in Account Payables history runs 5 years deep, the most recent figure standing at -$4.2 million for Q4 2025.
- Quarterly Change in Account Payables rose 41.76% year-over-year to -$4.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.2 million (up 32.52% YoY) and the FY2025 annual result came in at $3.2 million, up 32.52% from the prior year.
- Change in Account Payables was -$4.2 million for Q4 2025 at Invivyd, down from -$218000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $12.9 million in Q1 2022 and bottomed at -$14.7 million in Q4 2022.
- A 5-year average of $271750.0 and a median of -$611500.0 in 2021 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 443.75% in 2024, while the deepest fall reached 500.58% in 2024.
- Invivyd's Change in Account Payables stood at -$11.3 million in 2021, then sank by 30.07% to -$14.7 million in 2022, then soared by 91.73% to -$1.2 million in 2023, then tumbled by 500.58% to -$7.3 million in 2024, then jumped by 41.76% to -$4.2 million in 2025.
- Business Quant data shows IVVD's Change in Account Payables at -$4.2 million in Q4 2025, -$218000.0 in Q3 2025, and $9.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | -4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.25 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Sep 30, 2025 | -218,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | 9.31 Mn |
| Jun 30, 2025 | 9.31 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Sep 30, 2024 | 10.31 Mn |
| Sep 30, 2024 | 10.31 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | -6.79 Mn |
| Mar 31, 2024 | -6.79 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Sep 30, 2023 | 5.06 Mn |